Business
Wellbeing Digital Sciences Becomes a Founding Sponsor of the Women in Psychedelics Network
Wellbeing Digital Sciences Becomes a Founding Sponsor of the Women in Psychedelics Network.
About this update from Wellbeing Digital Sciences Inc.
[{"type":"text","content":"\n VANCOUVER, British Columbia, May 10, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research is pleased to announce that it has become a founding sponsor of the Women in Psychedelics Network (the “WIP” or the ”WIP”). Both Wellbeing and its subsidiary, KGK Science Inc. (“KGK”), are founding supporters of the WIP, as led by Najla Guthrie. WIP was created to bring women together in the psychedelic industry, of every discipline, and build a community based on education, support, growth, and experience. More information about WIP can be found on its website via the following URL: https://womeninpsychedelicsnetwork.com/. The formation of WIP is to make a long-term impact on the psychedelic space, by bringing together a diverse group of women in this space and to be a voice for all women going forward regarding their developments, achievements and challenges. Information sharing, expertise and collaboration are a few of the many elements that the founders of WIP believe will help advocate and represent the women who are part of the psychedelic medicine industry. Although times are changing and women in all fields are beginning to be recognized and valued, as they should be, the formation of the WIP is being developed to bring brilliant female minds together and have them be represented in the psychedelics sector. WIP will look to recruit healthcare representatives, scientists, and company leaders, as well as sponsorships from companies that may not be led by women but are support WIP. Najla Guthrie, Chief Executive Officer of Wellbeing, and now the founder of WIP, has demonstrated a strong desire to mentor and lead, as an advocate for psychedelic compounds as medicine for mental health. Ms. Guthrie has played a major role in growing KGK into a leading North American contract research organization that provides high quality clinical trials with a focus on emerging psychedelic industries. She has published over 50 peer-reviewed papers and has given multiple presentations at both national and inter...